An Open-Label, Long-Term Safety Study of SD-809 (deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
Laufzeit: 01.01.2016 - 31.12.2020
Kurzfassung
This is an open-label, single-arm study in which subjects with moderate to severe TD who have successfully completed a parent study (Study SD-809-C-18, Study SD-809-C-23, or any other controlled study of SD-809 for the treatment of moderate to severe TD) will be invited to participate
